<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04637347</url>
  </required_header>
  <id_info>
    <org_study_id>CIS UTSCVC</org_study_id>
    <nct_id>NCT04637347</nct_id>
  </id_info>
  <brief_title>SC vs IC Approach for US-guided SC Vein Catheterization</brief_title>
  <acronym>USIC</acronym>
  <official_title>Comparaison Between Ultrasound-guided Supraclavicular and Infraclavicular Approaches for Subclavian Venous Catheterization in Intensive Care Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Tunis El Manar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Tunis El Manar</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients were randomly divided into two groups: ultrasound-guided (US-guided) in-plane&#xD;
      infraclavicular subclavian vein (IP-ISV) and in-plane supraclavicular subclavian vein&#xD;
      (IP-SSV) catheterization.&#xD;
&#xD;
      For IP-ISV cannulation, a linear transducer is placed in the infraclavicular fossa. After&#xD;
      obtaining a long-axis view of the axillary vein and distal subclavian vein ,the needle is&#xD;
      inserted in the midpoint of the small footprint transducer. Then,the needle is advanced under&#xD;
      real-time US guidance until visualizing the tip of the needle inside the vein while noticing&#xD;
      the lung pleura underneath the vessels.&#xD;
&#xD;
      For IP-SSV cannulation, a short-axis view of the IJV is obtained first. The probe is slid&#xD;
      caudally following the IJV until getting the best long-axis view of the SCV. Using an&#xD;
      in-plane approach, the needle is inserted at the base of the transducer at a 30° angle and&#xD;
      advanced under the long axis under real-time US guidance targeting the SCV.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients were randomly divided into two groups: ultrasound-guided (US-guided) in-plane&#xD;
      infraclavicular subclavian vein (IP-ISV) and in-plane supraclavicular subclavian vein&#xD;
      (IP-SSV) catheterization.&#xD;
&#xD;
      For IP -ISV, the Linear transducer is placed perpendicularly and inferior to clavicle.&#xD;
      Transverse (short axis) view of subclavian vein (SCV), subclavian artery (SCA) and pleura is&#xD;
      first obtained. With SCV centrally positioned, the transducer is rotated 90° clockwise until&#xD;
      longitudinal view of subclavian vein is obtained. Pulse-wave Doppler view of the SCV confirms&#xD;
      non-pulsatile flow and identifies the vessel. The needle is than inserted in the midpoint of&#xD;
      the small footprint transducer using the in-plane approach. The needle is advanced slowly,&#xD;
      under real-time US guidance targeting the SCV, taking note of the lung pleura underneath the&#xD;
      vessels.&#xD;
&#xD;
      For IP-SSV cannulation, a short-axis view of the IJV is first obtained . The probe is slid&#xD;
      caudally following the IJV until the junction of the subclavian vein (SCV) and IJV is reached&#xD;
      in the supraclavicular fossa. The probe is then turned slightly and tilted anteriorly to get&#xD;
      the best long-axis view of the SCV and the brachiocephalic vein .&#xD;
&#xD;
      Using an in-plane approach, the needle attached to a syringe is inserted at the base of the&#xD;
      transducer at a 30° angle and advanced strictly under the long axis of the US probe from&#xD;
      lateral to medial. The needle point is then guided.&#xD;
&#xD;
      In both groups, catheterization was done through Seldinger technique.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Actual">June 30, 2021</completion_date>
  <primary_completion_date type="Actual">May 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The overall access time</measure>
    <time_frame>During the venous cannulation procedure</time_frame>
    <description>Time from the ultrasound scanning to the ultrasound confirmation of the correct position of the guidewire into vein.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The guidewire time</measure>
    <time_frame>During the venous cannulation procedure</time_frame>
    <description>Time from the first skin puncture to the ultrasound confirmation of the correct placement of the guidewire into the vein</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The venous access time</measure>
    <time_frame>During the venous cannulation procedure</time_frame>
    <description>he time between the first skin puncture and free aspiration of venous blood in the syringe</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Central Venous Catheter</condition>
  <arm_group>
    <arm_group_label>IP-ISV</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>In plane infraclavicular subclavian vein catheterization</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IP-SSV</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>In plane supraclavicular subclavian vein catetherization</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Catheterization approach</intervention_name>
    <description>In plane infraclavicular subclavian vein VS in plane supraclavicular subclavian vein catetherization</description>
    <arm_group_label>IP-ISV</arm_group_label>
    <arm_group_label>IP-SSV</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients admitted in intensive care unit requiring a central venous catheter (CVC)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Major blood coagulation disorders,&#xD;
&#xD;
          -  Any thrombotic formations within the vein,&#xD;
&#xD;
          -  Congenital or acquired deformity of neck or clavicle&#xD;
&#xD;
          -  Cannulation site infection, hematoma and surgery.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>BEN ALI MECHAAL, PROFESSOR</last_name>
    <role>Study Chair</role>
    <affiliation>University Tunis El Manar</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mrezga Nabeul Tunisie</name>
      <address>
        <city>Nabeul</city>
        <zip>8000</zip>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>November 14, 2020</study_first_submitted>
  <study_first_submitted_qc>November 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 19, 2020</study_first_posted>
  <last_update_submitted>August 23, 2021</last_update_submitted>
  <last_update_submitted_qc>August 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Tunis El Manar</investigator_affiliation>
    <investigator_full_name>Trabelsi Becem</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

